Table 1 IMN in pediatric patients: clinical and laboratory data (N = 13)
Initial Visit N (%) | Final Visit n (%) | |
|---|---|---|
Mean Age | 9.6 ± 4.6 | -- |
Gender | 6 M:7 F | -- |
Ethnicity | 8 W:2 B:3 H | -- |
Hematuria | 9 (69%) | 6 (46%) |
Peripheral Edema | 5 (38%) | 0 |
Proteinuria (protein:creatinine ratio) | 3.3 ± 2.5 | 2.3 ± 3.1 |
Nephrotic-range Proteinuria | 5 (38%) | 3 (23%) |
Hypoalbuminemia | 6 (46%) | 5 (38%) |
Hypertension | 3 (23%) | 7 (54%) |
Hypercholesterolemia | 10 (77%) | 5 (38%) |
GFR e mL/min/m 2 | 155 ± 34 | 127 ± 57 |
CKD Stage 3–5 | 0 | 3 (23%) |